메뉴 건너뛰기




Volumn 288, Issue 37, 2013, Pages 26583-26593

Development of a human IgG4 bispecific antibody for dual targeting of interleukin-4 (IL-4) and interleukin-13 (IL-13) cytokines

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINES; IN-VITRO; IN-VIVO; INTERLEUKIN-13; INTERLEUKIN-4;

EID: 84884194586     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M113.480483     Document Type: Article
Times cited : (61)

References (42)
  • 1
    • 84858257263 scopus 로고    scopus 로고
    • Dual targeting strategies with bispecific antibodies
    • Kontermann, R. (2012) Dual targeting strategies with bispecific antibodies. MAbs 4, 182-197
    • (2012) MAbs , vol.4 , pp. 182-197
    • Kontermann, R.1
  • 2
    • 84856808226 scopus 로고    scopus 로고
    • World bispecific antibody summit
    • September 27-28, 2011, Boston, MA
    • Dhimolea, E., and Reichert, J. M. (2012) World Bispecific Antibody Summit, September 27-28, 2011, Boston, MA. MAbs 4, 4-13
    • (2012) MAbs , vol.4 , pp. 4-13
    • Dhimolea, E.1    Reichert, J.M.2
  • 4
    • 0037144397 scopus 로고    scopus 로고
    • Albumin binding as a general strategy for improving the pharmacokinetics of proteins
    • Dennis, M. S. (2002) Albumin binding as a general strategy for improving the pharmacokinetics of proteins. J. Biol. Chem. 277, 35035-35043
    • (2002) J. Biol. Chem. , vol.277 , pp. 35035-35043
    • Dennis, M.S.1
  • 5
    • 0031552589 scopus 로고    scopus 로고
    • Stable heterodimers from remodeling the domain interface of a homodimer using a phage display library
    • Atwell, S., Ridgway, J. B., Wells, J. A., and Carter, P. (1997) Stable heterodimers from remodeling the domain interface of a homodimer using a phage display library. J. Mol. Biol. 270, 26-35
    • (1997) J. Mol. Biol. , vol.270 , pp. 26-35
    • Atwell, S.1    Ridgway, J.B.2    Wells, J.A.3    Carter, P.4
  • 6
    • 0029946383 scopus 로고    scopus 로고
    • "knobs-into-holes" engineering of antibody CH3 domains for heavy chain heterodimerization
    • Ridgway, J. B., Presta, L. G., and Carter, P. (1996) "Knobs-into- holes" engineering of antibody CH3 domains for heavy chain heterodimerization. Protein Eng. 9, 617-621
    • (1996) Protein Eng. , vol.9 , pp. 617-621
    • Ridgway, J.B.1    Presta, L.G.2    Carter, P.3
  • 7
    • 77954628740 scopus 로고    scopus 로고
    • SEEDbodies. Fusion proteins based on strand-exchange engineered domain (SEED) CH3 heterodimers in an Fc analogue platform for asymmetric binders or immunofusions and bispecific antibodies
    • Davis, J. H., Aperlo, C., Li, Y., Kurosawa, E., Lan, Y., Lo, K.-M., and Huston, J. S. (2010) SEEDbodies. Fusion proteins based on strand-exchange engineered domain (SEED) CH3 heterodimers in an Fc analogue platform for asymmetric binders or immunofusions and bispecific antibodies. Protein Eng. Des. Sel. 23, 195-202
    • (2010) Protein Eng. Des. Sel. , vol.23 , pp. 195-202
    • Davis, J.H.1    Aperlo, C.2    Li, Y.3    Kurosawa, E.4    Lan, Y.5    Lo, K.-M.6    Huston, J.S.7
  • 13
    • 84871565611 scopus 로고    scopus 로고
    • LUZ-Y, a novel platform for the mammalian cell production of full-length IgG-bispecific antibodies
    • Wranik, B. J., Christensen, E. L., Schaefer, G., Jackman, J. K., Vendel, A. C., and Eaton, D. (2012) LUZ-Y, a novel platform for the mammalian cell production of full-length IgG-bispecific antibodies. J. Biol. Chem. 287, 43331-43339
    • (2012) J. Biol. Chem. , vol.287 , pp. 43331-43339
    • Wranik, B.J.1    Christensen, E.L.2    Schaefer, G.3    Jackman, J.K.4    Vendel, A.C.5    Eaton, D.6
  • 17
    • 0037393323 scopus 로고    scopus 로고
    • IL-13 receptors and signaling pathways. An evolving web
    • quiz 691
    • Hershey, G. K. (2003) IL-13 receptors and signaling pathways. An evolving web. J. Allergy Clin. Immunol. 111, 677-690 ; quiz 691
    • (2003) J. Allergy Clin. Immunol. , vol.111 , pp. 677-690
    • Hershey, G.K.1
  • 18
    • 0037775352 scopus 로고    scopus 로고
    • IL-13 effector functions
    • Wynn, T. A. (2003) IL-13 effector functions. Annu. Rev. Immunol. 21, 425-456
    • (2003) Annu. Rev. Immunol. , vol.21 , pp. 425-456
    • Wynn, T.A.1
  • 19
    • 38649137731 scopus 로고    scopus 로고
    • Molecular and structural basis of cytokine receptor pleiotropy in the interleukin-4/13 system
    • LaPorte, S. L., Juo, Z. S., Vaclavikova, J., Colf, L. A., Qi, X., Heller, N. M., Keegan, A. D., and Garcia, K. C. (2008) Molecular and structural basis of cytokine receptor pleiotropy in the interleukin-4/13 system. Cell 132, 259-272
    • (2008) Cell , vol.132 , pp. 259-272
    • Laporte, S.L.1    Juo, Z.S.2    Vaclavikova, J.3    Colf, L.A.4    Qi, X.5    Heller, N.M.6    Keegan, A.D.7    Garcia, K.C.8
  • 20
    • 0037064548 scopus 로고    scopus 로고
    • Structure, binding, and antagonists in the IL-4/IL-13 receptor system
    • Mueller, T. D., Zhang, J.-L., Sebald, W., and Duschl, A. (2002) Structure, binding, and antagonists in the IL-4/IL-13 receptor system. Biochim. Biophys. Acta 1592, 237-250
    • (2002) Biochim. Biophys. Acta , vol.1592 , pp. 237-250
    • Mueller, T.D.1    Zhang, J.-L.2    Sebald, W.3    Duschl, A.4
  • 22
    • 9644281044 scopus 로고    scopus 로고
    • Interleukin-13 in asthma pathogenesis
    • Wills-Karp, M. (2004) Interleukin-13 in asthma pathogenesis. Immunol. Rev. 202, 175-190
    • (2004) Immunol. Rev. , vol.202 , pp. 175-190
    • Wills-Karp, M.1
  • 23
  • 24
  • 26
    • 0035719975 scopus 로고    scopus 로고
    • Th2 cytokines and asthma interleukin-its role in the pathogenesis of asthma, and targeting it for asthma treatment with interleukin-4 receptor antagonists
    • Steinke, J. W., and Borish, L. (2001) Th2 cytokines and asthma. Interleukin-Its role in the pathogenesis of asthma, and targeting it for asthma treatment with interleukin-4 receptor antagonists. Respir. Res. 2, 66-70
    • (2001) Respir. Res. , vol.2 , pp. 66-70
    • Steinke, J.W.1    Borish, L.2
  • 30
    • 84869100349 scopus 로고    scopus 로고
    • IL-13 in asthma and allergic disease. Asthma phenotypes and targeted therapies
    • quiz 843-844
    • Ingram, J. L., and Kraft, M. (2012) IL-13 in asthma and allergic disease. Asthma phenotypes and targeted therapies. J. Allergy Clin. Immunol. 130, 829-842; quiz 843-844
    • (2012) J. Allergy Clin. Immunol. , vol.130 , pp. 829-842
    • Ingram, J.L.1    Kraft, M.2
  • 31
    • 80054733269 scopus 로고    scopus 로고
    • Attacks on asthma
    • Webb, S. (2011) Attacks on asthma. Nat. Biotechnol. 29, 860-863
    • (2011) Nat. Biotechnol. , vol.29 , pp. 860-863
    • Webb, S.1
  • 34
    • 84883799831 scopus 로고    scopus 로고
    • (Kontermann, R., and Dübel, S., eds) Springer, Berlin
    • Reilly, D. E., and Yansura, D. G. (2010) Antibody Engineering (Kontermann, R., and Dübel, S., eds), pp. 331-344, Springer, Berlin
    • (2010) Antibody Engineering , pp. 331-344
    • Reilly, D.E.1    Yansura, D.G.2
  • 36
    • 0036161996 scopus 로고    scopus 로고
    • IgG4 breaking the rules
    • Aalberse, R. C., and Schuurman, J. (2002) IgG4 breaking the rules. Immunology 105, 9-19
    • (2002) Immunology , vol.105 , pp. 9-19
    • Aalberse, R.C.1    Schuurman, J.2
  • 37
    • 15744375548 scopus 로고    scopus 로고
    • The nonconsecutive disulfide bond of Escherichia coli phytase (AppA) renders it dependent on the protein-disulfide isomerase, DsbC
    • Berkmen, M. (2005) The nonconsecutive disulfide bond of Escherichia coli phytase (AppA) renders it dependent on the protein-disulfide isomerase, DsbC. J. Biol. Chem. 280, 11387-11394
    • (2005) J. Biol. Chem. , vol.280 , pp. 11387-11394
    • Berkmen, M.1
  • 38
    • 0032581013 scopus 로고    scopus 로고
    • Contribution of domain interface residues to the stability of antibody CH3 domain homodimers
    • Dall'Acqua, W., Simon, A. L., Mulkerrin, M. G., and Carter, P. (1998) Contribution of domain interface residues to the stability of antibody CH3 domain homodimers. Biochemistry 37, 9266-9273
    • (1998) Biochemistry , vol.37 , pp. 9266-9273
    • Dall'acqua, W.1    Simon, A.L.2    Mulkerrin, M.G.3    Carter, P.4
  • 39
    • 73149121904 scopus 로고    scopus 로고
    • Impact of molecular processing in the hinge region of therapeutic IgG4 antibodies on disposition profiles in cynomolgus monkeys
    • Stubenrauch, K., Wessels, U., Regula, J. T., Kettenberger, H., Schleypen, J., and Kohnert, U. (2010) Impact of molecular processing in the hinge region of therapeutic IgG4 antibodies on disposition profiles in cynomolgus monkeys. Drug Metab. Dispos. 38, 84-91
    • (2010) Drug Metab. Dispos. , vol.38 , pp. 84-91
    • Stubenrauch, K.1    Wessels, U.2    Regula, J.T.3    Kettenberger, H.4    Schleypen, J.5    Kohnert, U.6
  • 41
    • 78650479011 scopus 로고    scopus 로고
    • What is IgG4? A review of the biology of a unique immunoglobulin subtype
    • Nirula, A., Glaser, S. M., Kalled, S. L., and Taylor, F. R. (2011) What is IgG4? A review of the biology of a unique immunoglobulin subtype. Curr. Opin. Rheumatol. 23, 119-124
    • (2011) Curr. Opin. Rheumatol. , vol.23 , pp. 119-124
    • Nirula, A.1    Glaser, S.M.2    Kalled, S.L.3    Taylor, F.R.4
  • 42
    • 80052622662 scopus 로고    scopus 로고
    • Bypassing glycosylation. Engineering aglycosylated full-length IgG antibodies for human therapy
    • Jung, S. T., Kang, T. H., Kelton, W., and Georgiou, G. (2011) Bypassing glycosylation. Engineering aglycosylated full-length IgG antibodies for human therapy. Curr. Opin. Biotechnol. 22, 858-867
    • (2011) Curr. Opin. Biotechnol. , vol.22 , pp. 858-867
    • Jung, S.T.1    Kang, T.H.2    Kelton, W.3    Georgiou, G.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.